Trinity Biotech Plc: Company Strategy, SWOT Analysis and 5-year Adjusted Financials
Scope
Report Highlights
Reasons to Purchase
Table of Contents
- Overview - page 1
- Catalyst - page 1
- Summary - page 1
- Table of Contents - page 2
- Table of figures - page 3
- Table of tables - page 4
- Company Structure - page 5
- Company Overview and Key Facts - page 5
- Business Description - page 6
- History - page 7
- M&A History - page 8
- Haemostasis line of bioMerieux - page 8
- Distribution business of Laboratoires Nephrotek SARL - page 8
- Primus Corporation - page 8
- Research Diagnostics - page 8
- Adaltis US - page 9
- Fitzgerald Industries International - page 9
- Specialty Clinical Chemistry business from Sigma Diagnostics - page 9
- Hemostasis division of Sigma Diagnostics - page 9
- Biopool hemostasis business - page 9
- MarDx Diagnostics - page 10
- Bartels - page 10
- M&A History - page 8
- Locations and Subsidiaries - page 11
- Company Financials - page 12
- Stock Market Performance - page 12
- P&L - page 13
- Balance Sheet - page 16
- Cash Flow - page 16
- Geographic Segment Performance - page 17
- Products & Services - page 18
- Products - page 18
- Haemostasis - page 18
- Point of Care (POC) - page 18
- Infectious Diseases - page 18
- Clinical Chemistry - page 19
- Historical Product Sales - page 20
- AC Forecast Product Sales - page 22
- Products - page 18
- Competitors and Strategic Business Relationships - page 23
- Key Competitors - page 23
- Key Suppliers - page 24
- Key Clients - page 24
- Strategy - page 25
- Company View - page 25
- Corporate Strategy - page 27
- SWOT Analysis - page 29
- Overview - page 29
- Strengths - page 30
- Broad product portfolio - page 30
- Weaknesses - page 31
- Declining profitability - page 31
- Opportunities - page 32
- New product launches - page 32
- Growing incidence of diabetes - page 32
- Threats - page 33
- Cost containment pressures - page 33
- Medical equipment industry consolidation - page 33
- Value Chain Analysis - page 34
- Product Development - page 35
- Manufacturing - page 35
- Sales - page 35
- Key Employees - page 36
- List of Employees - page 36
- Key Employee Biographies - page 37
- Ronan O'Caoimh - page 37
- Brendan Farrell - page 37
- Kevin Tansley - page 38
- Rory Nealon - page 38
- Denis R Burger - page 38
- Peter Coyne - page 39
- Financial and Operational Overview - page 40
- APPENDIX - page 42
- Ask the analyst - page 42
- Datamonitor consulting - page 42
- Disclaimer - page 42
- List of Tables
- Table 1: Trinity Biotech - Key Facts - page 5
- Table 2: Trinity Biotech - Locations and Subsidiaries - page 11
- Table 3: Trinity Biotech - Year-End Share Price and Market Capitalization, 2002-2006 ($) - page 12
- Table 4: Trinity Biotech - Key Events Impacting Share Price Performance - page 12
- Table 5: Trinity Biotech - Operating Revenue/Cost Analysis, 2002-2006 ($ Mn) - page 13
- Table 6: Trinity Biotech - Operating Cost Ratio Analysis, 2002-2006 (% of total revenues) - page 15
- Table 7: Trinity Biotech - Balance Sheet - page 16
- Table 8: Trinity Biotech - Cash Flow - page 16
- Table 9: Trinity Biotech - Geographic Breakdown, 2002-2006 ($ Mn) - page 17
- Table 10: Trinity Biotech - Marketed Products - page 18
- Table 11: Trinity Biotech - Historical Product Sales, 2002-2006 ($ Mn) - page 20
- Table 12: Trinity Biotech - Forecast Sales, 2006-2010 ($ Mn) - page 22
- Table 13: Trinity Biotech - Key Competitors - page 23
- Table 14: Trinity Biotech - Key Suppliers - page 24
- Table 15: Trinity Biotech - SWOT Analysis Summary - page 29
- Table 16: Trinity Biotech - Value Chain Analysis - page 34
- Table 17: Trinity Biotech - Key Employees - page 36
- Table 18: Trinity Biotech- Financial and Operational Overview - page 40
- List of Figures
- Figure 1: Trinity Biotech - Operating Revenue/Cost Analysis, 2002-2006 ($ Mn) - page 14
- Figure 2: Trinity Biotech - Key Strategic Revenues, 2002-2006 ($ Mn) - page 21
Other users found this report page using the following search terms: biotech swot trinity analysis company max haemostasis laboratory companies price
If you can't find a report that meets your needs contact LeadDiscovery. We are one of the few report providers with extensive drug development experience and we frequently use this knowledge to help clients source the most appropriate reports or produce reports for them from scratch.
Refund and Cancellation Policy: The descriptions of the products and services sold on LeadDiscovery.co.uk are as complete and accurate as possible, and customers are encouraged to read all available information about a product before placing an order. Due to the nature of the information being sold, orders for reports cannot be canceled.